Minocycline, a possible neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): Studies of cybrid cells bearing 11778 mutation

@article{Haroon2007MinocyclineAP,
  title={Minocycline, a possible neuroprotective agent in Leber’s hereditary optic neuropathy (LHON): Studies of cybrid cells bearing 11778 mutation},
  author={Mohammad Fahad Haroon and Ambrin. Fatima and Susanne Sch{\"o}ler and Anne Gieseler and Thomas F. W. Horn and Elmar Kirches and Gerald Wolf and Peter Kreutzmann},
  journal={Neurobiology of Disease},
  year={2007},
  volume={28},
  pages={237-250}
}

Figures from this paper

LHON: Mitochondrial Mutations and More
TLDR
The hypothesis of bioenergetic failure does not provide a simple explanation for the relatively late disease onset and for the incomplete penetrance, which differs remarkably between genders.
Therapeutic strategies for Leber's hereditary optic neuropathy: A current update.
TLDR
This commentary gives a brief overview on the current status of tested therapeutics and also addresses future developments such as the use of gene therapy that hopefully will provide safe and efficient therapy options for all LHON patients.
Advances in therapeutic strategies for Leber’s hereditary optic neuropathy
TLDR
Avoidance of triggers which generate reactive oxygen species and treatment with idebenone is the best currently available therapy for LHON.
Inhibitory modulation of the mitochondrial permeability transition by minocycline.
Minocycline Recovers MTT-Formazan Exocytosis Impaired by Amyloid Beta Peptide
TLDR
Intriguingly, the Aβ-triggered increase in MTT-formazan exocytosis was abolished by co-treatment with minocycline and has to be noticed in the elucidation of the underlying mechanism of this promising neuroprotectant.
Functional Characterization of Three Concomitant MtDNA LHON Mutations Shows No Synergistic Effect on Mitochondrial Activity
TLDR
The first example of a mtDNA molecule harboring three Leber's hereditary optic neuropathy (LHON)-associated mutations is described and its genetic, biochemical and molecular characterization in transmitochondrial cells (cybrids) reveals no differences in mitochondrial function.
Respiratory Complex I Dysfunction Due to Mitochondrial DNA Mutations Shifts the Voltage Threshold for Opening of the Permeability Transition Pore toward Resting Levels*
TLDR
Findings indicate that depolarization by respiratory chain inhibitors and oligomycin was due to opening of the mitochondrial permeability transition pore (PTP), and a shift of the threshold voltage for PTP opening close to the resting potential may be the underlying cause facilitating cell death in diseases affecting complex I activity.
HEREDITARY OPTIC NEUROPATHY, IS THERE A TREATMENT?
TLDR
The natural history of visual loss in these clinical settings is discussed, specifically the prognosis for spontaneous visual recovery, and the evidence currently available on the treatment of these disorders is reviewed.
Impairment of mitochondrial function by minocycline
TLDR
It is found that MC at low micromolar concentrations impairs several energy‐dependent functions of mitochondria in’vitro.
...
...

References

SHOWING 1-10 OF 55 REFERENCES
Caspase-independent death of Leber’s hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G
TLDR
The caspase-independent death of LHON cybrids incubated in galactose medium is triggered by rapid ATP depletion and mediated by AIF and EndoG.
Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy
TLDR
The data suggest that, in cells carrying LHON mutations, there is a decrease in antioxidant defences, which is especially evident in cells with mutations associated with the most severe clinical phenotype, and this is magnified by stressful conditions such as exposure to galactose.
Leber's hereditary optic neuropathy
TLDR
The results imply that biochemical studies on mitochondrial diseases should always be integrated with mt DNA analysis of the same tissue investigated and suggest that the mtDNA analysis on the leukocyte fraction, as usually performed in LHON, does not necessarily reflect the mutant genotype level of other tissues.
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines.
TLDR
These findings support the hypothesis that the genetically determined mitochondrial dysfunction in LHON patients leads to impaired activity of the EAAT1 glutamate transporter, which is the major means of glutamate removal in the inner retina and this prevents retinal ganglion cells being damaged as a result of excitotoxicity.
Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids.
TLDR
The pathogenic mutations of LHON profoundly impair complex I-dependent synthesis of ATP, providing a common biochemical feature that may play a major role in LHON pathogenesis.
Biochemical features of mtDNA 14484 (ND6/m64V) point mutation associated with Leber's hereditary optic neuropathy
TLDR
The results suggest that both 14484 and 14459 mutations may affect amino acids forming the interaction site of ubiquinol product, and the 14484 mutation produces a biochemical defect resembling in part that already reported for the common 11778/ND4 LHON mutation.
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
TLDR
It is found that minocycline inhibits mitochondrial permeability-transition-mediated cytochrome c release, and this drug may be a novel therapy for ALS.
Glutathione depletion in antioxidant defense of differentiated NT2-LHON cybrids
[Leber's hereditary optic neuropathy].
TLDR
The diagnosis of LHON and genetic counselling in affected families should be based on close collaboration of ophthalmological and genetic departments with specialized laboratories engaged in molecular biological diagnosis of mitochondrial diseases.
...
...